[Research advances in mitochondrial dysfunction-mediated sepsis-associated encephalopathy]

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Sepsis-associated encephalopathy (SAE) causes significant cognitive impairment, increasing mortality and disability.
• Current interventions for SAE cognitive dysfunction are limited and in early preclinical stages.
• Mitochondrial dysfunction is a key pathogenic mechanism in SAE, affecting energy metabolism and apoptosis.

Purpose of the Study:

• To systematically review recent research on mitochondrial dysfunction in SAE cognitive disorders.
• To explore novel mitochondria-targeted interventions for improving cognitive function in SAE patients.
• To provide a theoretical basis for advancing clinical treatment of SAE.

Main Methods:

• Systematic integration of recent studies on mitochondrial dysfunction in SAE.
• Discussion of mitochondrial structural and kinetic abnormalities, and respiratory chain dysfunction.
• Comprehensive review of research on mitochondria-targeted therapies.

Main Results:

• Mitochondrial dysfunction contributes to SAE through oxidative stress, energy metabolism disruption, and apoptosis.
• Research highlights mitochondrial structural disruption, kinetic abnormalities, and respiratory chain dysfunction in SAE.
• Novel strategies include mitochondria-targeted antioxidants, autophagy activators, and biosynthesis modifiers.

Conclusions:

• Mitochondrial dysfunction is central to SAE pathogenesis and cognitive decline.
• Targeting mitochondria presents a promising therapeutic avenue for SAE.
• Further research into mitochondria-targeted interventions could revolutionize SAE treatment.